Russian medicine has taken a significant step forward with the registration of a new radiopharmaceutical drug, "Rakurs (223Ra)," which has been approved by the FMBA of Russia. Here are the details.
This is a domestic development, representing an innovative solution for patients with prostate cancer. The drug has a dual action: it not only effectively destroys metastases in the bones but also significantly reduces pain.
Selectively accumulating in the bones, "Rakurs (223Ra)" provides a highly localized antitumor effect, which helps to prolong the life of patients and improve its quality. Thanks to this, many patients will be able to abandon painkillers, which is an important step towards more comfortable treatment.
Developed at the Federal Scientific and Clinical Center for Medical Radiology and Oncology (FSCCMRO) in Dimitrovgrad, "Rakurs" has the potential to expand indications and applications in the treatment of metastatic bone lesions that occur in other forms of tumor diseases. The registration of this drug will not only reduce logistical delays but also make it more accessible to Russian citizens.
The radionuclide 223Ra, used in the drug, is supplied by the State Scientific Center "NIIAR," which emphasizes the high standards and reliability of domestic production. "Rakurs" is intended for radionuclide therapy of patients with castration-resistant prostate cancer suffering from bone metastases.
Read more on the topic:
The only drug against cancer based on a virus in Russia has passed the first tests
In Russia, the cancer vaccine will be free for all Russians
A new technology for producing cancer drugs has been developed at the Khlopin Radium Institute
Now on home
Герой России Гарнаев: никто из профессионалов о возобновлении производства на КАЗ всерьёз не говорит
Система отслеживает спутники на высотах до 50 000 км и ведёт за ними наблюдение
The armored vehicle is equipped with a KamAZ-740.35-400 diesel engine with a power of 400 hp.
Constant improvements in avionics, weapons and tactical capabilities will make the aircraft a flexible response to future challenges
The exterior of the KamAZ-54901 features fairings on the cab and chassis for fuel economy
Fighters are in demand both domestically and abroad
Tyazhpromexport and Venezuela Agree on Plant Revival
The company not only completed the state order, but also quickly mastered the production of AK-12K for special forces
Experts have developed a photogrammetric complex with a resolution of less than 1 cm
